Logatiman, Ana Marie C.

HRN: 21-42-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2022
CEFUROXIME 500MG (TAB)
05/18/2022
05/24/2022
ORAL
500mg
BID
S/P RMLE 4th Degree
Waiting Final Action 
05/18/2022
METRONIDAZOLE 500MG (TAB)
05/18/2022
05/24/2022
ORAL
500mg
TID
S/P RMLE 4th Degree Laceration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: